Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …

Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be
promptly diagnosed and treated. The diagnosis, risk assessment, and management of …

The incidence of venous thromboembolism (VTE) in cancer patients may have changed in
the past decade, possibly due to novel cancer therapies, improved survival, and high …

Cancer-associated thrombosis (CAT) is an important cause of morbidity and mortality for
patients with malignancy and varies by primary cancer type, stage, and therapy. We aimed …

In cancer patients, thrombocytopenia can result from bone marrow infiltration or from
anticancer medications and represents an important limitation for the use of antithrombotic …

Purpose To evaluate the diagnostic efficacy of artificial intelligence (AI) software in detecting
incidental pulmonary embolism (IPE) at CT and shorten the time to diagnosis with use of …

The association between malignancy and thrombosis has been recognized for over a
century and a half. Patients with cancer have an elevated risk of both initial and recurrent …

Background The optimal duration of anticoagulation in patients with active cancer and
venous thromboembolism (VTE) is unknown. Current clinical guidelines advocate …

Background Venous thromboembolism is associated with increased mortality risk in some
populations, but how frequently it is a direct cause of death is unclear. We used data from …

Background Acute pulmonary embolism (PE) is a common cause of death, accounting for
50,000 to 200,000 deaths annually. It is the third most common cause of mortality among the …